Two RSV vaccines have been approved for use in the U.S. in older adults, Arexvy and Abrysvo, and we’re entering our first respiratory virus season where these shots are available. RSV season usually ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

Veterans aged 60 years and older who received a single dose of the respiratory syncytial virus (RSV) prefusion F3 (RSVPreF3) or RSV prefusion F (RSVpreF) vaccine remained protecte ...

Vaccine uptake may not be much better during the 2024–25 respiratory virus season. Fewer than two in five (38%) eligible recipients plan to get an RSV vaccine, according to a survey conducted in ...

Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older ...

The RSV vaccine is specifically created and approved for administration in older adults. Back in March, the FDA recommended ...

Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it. While ...

The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...

First discovered in chimpanzees in 1956 and in children the following year, respiratory syncytial virus (RSV) isn’t new.